The importance of a timely second dose of the 2021 COVID-19 mRNA vaccine depends on the protection afforded by a first dose and subsequent risk of anaphylaxis

Publication date: Available online 20 April 2021Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Marcus Shaker, Elizabeth Phillips, Kimberly G. Blumenthal, Elissa M. Abrams, Aleena Banerji, John Oppenheimer, Timothy K. Vander Leek, Douglas P. Mack, Paige G. Wickner, Alexander G. Singer, David A. Khan, Matthew Greenhawt
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research